Ticker Scorecard - IMVT Basics Company: Immunovant, Inc. IPO Date: June 7, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.55B Activated in VL: True Average Daily Range Avg Daily Range: $0.54 | 2.77% Avg Daily Range (30 D): $0.46 | 1.87% Avg Daily Range (90 D): $0.51 | 1.88% Institutional Daily Volume Avg Daily Volume: .78M Avg Daily Volume (30 D): .89M Avg Daily Volume (90 D): .73M Trade Size Avg Trade Size (Sh.): 80 Avg Trade Size (Sh.) (30 D): 63 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 2,474 Avg Inst. Trade: $2.2M Avg Inst. Trade (30 D): $3.72M Avg Inst. Trade (90 D): $2.61M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.45M Avg Closing Trade (30 D): $5.46M Avg Closing Trade (90 D): $3.91M Avg Closing Volume: 145.81K     News Sep 9, 2024 @ 6:08 PM IMVT Stock Up on Upbeat Data From Graves' Disease ... Source: Zacks, Benzinga Contributor Sep 9, 2024 @ 7:55 AM Immunovant Provides Update on Graves’ Disea... Source: N/A Jul 4, 2024 @ 8:01 PM Thyroid Eye Disease Market to Accelerate Substanti... Source: Delveinsight Jun 28, 2024 @ 3:30 PM Immunovant (IMVT) Down 1.6% Since Last Earnings Re... Source: Zacks Equity Research May 30, 2024 @ 3:29 PM Immunovant (IMVT) Falls as Q4 Earnings Miss, Pipel... Source: Zacks Equity Research Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.22 $-.74 $-.6 Diluted EPS $-2.22 $-.74 $-.6 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -323.01M $ -109.12M $ -87.15M Operating Income / Loss $ $ $ Cost of Revenue $ $ $ Net Cash Flow $ 203.01M $ -87.06M $ -75.36M PE Ratio